Education
About Us
Working with TipRanks
Follow Us
Biovaxys Technology Corp (TSE:BIOV)
:BIOV
RESEARCH TOOLSreports
BIOV Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.08
Previous CloseN/A
Volume0.00
Average Volume (3M)386.44K
Market Cap
C$10.20M
Enterprise ValueN/A
Total Cash (Recent Filing)C$157.41K
Total Debt (Recent Filing)C$67.72K
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Jun 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding291,525,200
10 Day Avg. Volume191,215
30 Day Avg. Volume386,436
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-4.51
Price to Sales (P/S)0.00
P/FCF Ratio-3.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVaxys Technology News
PremiumCompany Announcements
BioVaxys and Sona Nanotech Collaborate on Innovative Cancer Therapeutics
PremiumCompany Announcements
BioVaxys and SpayVac Expand License to Target Aquaculture Market
PremiumCompany Announcements
BioVaxys Technology Corp. Revokes Cease Trade Order and Settles Debt
PremiumCompany Announcements
BioVaxys Technology Corp. Updates on Management Cease Trade Order Status
PremiumCompany Announcements
BioVaxys Settles Debt and Closes Final Private Placement Tranche
PremiumCompany Announcements
BioVaxys Faces Potential Filing Delay Amid Recent AcquisitionsOptions Prices
Currently, No data available
---
Ownership Overview
10.05% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
89.95% Public Companies and
Individual Investors
BIOV FAQ
What was Biovaxys Technology Corp’s price range in the past 12 months?
Biovaxys Technology Corp lowest stock price was C$0.03 and its highest was C$0.08 in the past 12 months.
What is Biovaxys Technology Corp’s market cap?
Biovaxys Technology Corp’s market cap is C$10.20M.
When is Biovaxys Technology Corp’s upcoming earnings report date?
Biovaxys Technology Corp’s upcoming earnings report date is Jun 26, 2025 which is in 31 days.
How were Biovaxys Technology Corp’s earnings last quarter?
Biovaxys Technology Corp released its earnings results on Mar 31, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Biovaxys Technology Corp overvalued?
According to Wall Street analysts Biovaxys Technology Corp’s price is currently Overvalued.
Does Biovaxys Technology Corp pay dividends?
Biovaxys Technology Corp does not currently pay dividends.
What is Biovaxys Technology Corp’s EPS estimate?
Biovaxys Technology Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biovaxys Technology Corp have?
Biovaxys Technology Corp has 291,525,200 shares outstanding.
What happened to Biovaxys Technology Corp’s price movement after its last earnings report?
Biovaxys Technology Corp reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of Biovaxys Technology Corp?
Currently, no hedge funds are holding shares in TSE:BIOV
Company Description
Biovaxys Technology Corp
BioVaxys Technology Corp. is a biotechnology company focused on developing viral and oncology vaccines as well as immuno-diagnostics. Operating in the life sciences sector, BioVaxys leverages its proprietary haptenization technology platform to create vaccines designed to elicit a robust immune response. The company is engaged in the development of vaccines for SARS-CoV-2, as well as therapeutic vaccines for ovarian cancer and other solid tumors.